U.S. Dialysis Market Trends & Forecast 2025–2034 

U.S. Dialysis Market - By Type, By End Use - Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Country

1.3.2&nbsp;&nbsp;&nbsp; Zonal/State

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Zonal trends

2.2.2&nbsp;&nbsp;&nbsp; Type trends

2.2.3&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising number of end stage renal diseases (ESRD) patients

3.2.1.2&nbsp;&nbsp;&nbsp; Increasing incidence of diabetes

3.2.1.3&nbsp;&nbsp;&nbsp; Shortage of donor kidneys

3.2.1.4&nbsp;&nbsp;&nbsp; Favourable reimbursement scenario available for dialysis treatment

3.2.1.5&nbsp;&nbsp;&nbsp; Growing R&amp;D investments

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Product recalls

3.2.2.2&nbsp;&nbsp;&nbsp; Complications in the treatment

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Growth in home dialysis adoption

3.2.3.2&nbsp;&nbsp;&nbsp; Development of biocompatible and high-efficiency membranes

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technology and innovation landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.6.1&nbsp;&nbsp;&nbsp; Impact of reimbursement policies on market growth

3.7&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.7.1&nbsp;&nbsp;&nbsp; Hemodialysis

3.7.2&nbsp;&nbsp;&nbsp; Peritoneal dialysis

3.8&nbsp;&nbsp;&nbsp; Historical timeline and industry evolution

3.9&nbsp;&nbsp;&nbsp; Consumer behaviour analysis

3.10&nbsp;&nbsp;&nbsp; Investment landscape

3.11&nbsp;&nbsp;&nbsp; Epidemiological scenario

3.12&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.13&nbsp;&nbsp;&nbsp; PESTEL analysis

3.14&nbsp;&nbsp;&nbsp; Gap analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers &amp; acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships &amp; collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Hemodialysis

5.2.1&nbsp;&nbsp;&nbsp; Equipment

5.2.1.1&nbsp;&nbsp;&nbsp; Dialysis machines

5.2.1.2&nbsp;&nbsp;&nbsp; Water treatment systems

5.2.2&nbsp;&nbsp;&nbsp; Consumables

5.2.2.1&nbsp;&nbsp;&nbsp; Dialyzers

5.2.2.2&nbsp;&nbsp;&nbsp; Catheters

5.2.2.3&nbsp;&nbsp;&nbsp; Access products

5.2.2.4&nbsp;&nbsp;&nbsp; Concentrates

5.2.2.5&nbsp;&nbsp;&nbsp; Other consumables

5.2.3&nbsp;&nbsp;&nbsp; Services

5.2.3.1&nbsp;&nbsp;&nbsp; Chronic dialysis

5.2.3.2&nbsp;&nbsp;&nbsp; Acute dialysis

5.3&nbsp;&nbsp;&nbsp; Peritoneal dialysis

5.3.1&nbsp;&nbsp;&nbsp; Equipment/Cyclers

5.3.2&nbsp;&nbsp;&nbsp; Consumables

5.3.2.1&nbsp;&nbsp;&nbsp; Peritoneal dialysis solution/Dialysate

5.3.2.1.1&nbsp;&nbsp;&nbsp; Dextrose

5.3.2.1.2&nbsp;&nbsp;&nbsp; Icodextrin

5.3.2.1.3&nbsp;&nbsp;&nbsp; Amino Acid

5.3.2.2&nbsp;&nbsp;&nbsp; Catheters

5.3.2.3&nbsp;&nbsp;&nbsp; Access products

5.3.2.4&nbsp;&nbsp;&nbsp; Other consumables

5.3.3&nbsp;&nbsp;&nbsp; Services

5.3.3.1&nbsp;&nbsp;&nbsp; Chronic dialysis

5.3.3.2&nbsp;&nbsp;&nbsp; Acute dialysis

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; In-center dialysis

6.3&nbsp;&nbsp;&nbsp; Home dialysis

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Zone, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; East North Central

7.2.1&nbsp;&nbsp;&nbsp; Illinois

7.2.2&nbsp;&nbsp;&nbsp; Indiana

7.2.3&nbsp;&nbsp;&nbsp; Michigan

7.2.4&nbsp;&nbsp;&nbsp; Ohio

7.2.5&nbsp;&nbsp;&nbsp; Wisconsin

7.3&nbsp;&nbsp;&nbsp; West South Central

7.3.1&nbsp;&nbsp;&nbsp; Arkansas

7.3.2&nbsp;&nbsp;&nbsp; Louisiana

7.3.3&nbsp;&nbsp;&nbsp; Oklahoma

7.3.4&nbsp;&nbsp;&nbsp; Texas

7.4&nbsp;&nbsp;&nbsp; South Atlantic

7.4.1&nbsp;&nbsp;&nbsp; Delaware

7.4.2&nbsp;&nbsp;&nbsp; Florida

7.4.3&nbsp;&nbsp;&nbsp; Georgia

7.4.4&nbsp;&nbsp;&nbsp; Maryland

7.4.5&nbsp;&nbsp;&nbsp; North Carolina

7.4.6&nbsp;&nbsp;&nbsp; South Carolina

7.4.7&nbsp;&nbsp;&nbsp; Virginia

7.4.8&nbsp;&nbsp;&nbsp; West Virginia

7.4.9&nbsp;&nbsp;&nbsp; Washington, D.C.

7.5&nbsp;&nbsp;&nbsp; Northeast

7.5.1&nbsp;&nbsp;&nbsp; Connecticut

7.5.2&nbsp;&nbsp;&nbsp; Maine

7.5.3&nbsp;&nbsp;&nbsp; Massachusetts

7.5.4&nbsp;&nbsp;&nbsp; New Hampshire

7.5.5&nbsp;&nbsp;&nbsp; Rhode Island

7.5.6&nbsp;&nbsp;&nbsp; Vermont

7.5.7&nbsp;&nbsp;&nbsp; New Jersey

7.5.8&nbsp;&nbsp;&nbsp; New York

7.5.9&nbsp;&nbsp;&nbsp; Pennsylvania

7.6&nbsp;&nbsp;&nbsp; East South Central

7.6.1&nbsp;&nbsp;&nbsp; Alabama

7.6.2&nbsp;&nbsp;&nbsp; Kentucky

7.6.3&nbsp;&nbsp;&nbsp; Mississippi

7.6.4&nbsp;&nbsp;&nbsp; Tennessee

7.7&nbsp;&nbsp;&nbsp; West North Central

7.7.1&nbsp;&nbsp;&nbsp; Iowa

7.7.2&nbsp;&nbsp;&nbsp; Kansas

7.7.3&nbsp;&nbsp;&nbsp; Minnesota

7.7.4&nbsp;&nbsp;&nbsp; Missouri

7.7.5&nbsp;&nbsp;&nbsp; Nebraska

7.7.6&nbsp;&nbsp;&nbsp; North Dakota

7.7.7&nbsp;&nbsp;&nbsp; South Dakota

7.8&nbsp;&nbsp;&nbsp; Pacific Central

7.8.1&nbsp;&nbsp;&nbsp; Alaska

7.8.2&nbsp;&nbsp;&nbsp; California

7.8.3&nbsp;&nbsp;&nbsp; Hawaii

7.8.4&nbsp;&nbsp;&nbsp; Oregon

7.8.5&nbsp;&nbsp;&nbsp; Washington

7.9&nbsp;&nbsp;&nbsp; Mountain States

7.9.1&nbsp;&nbsp;&nbsp; Arizona

7.9.2&nbsp;&nbsp;&nbsp; Colorado

7.9.3&nbsp;&nbsp;&nbsp; Utah

7.9.4&nbsp;&nbsp;&nbsp; Nevada

7.9.5&nbsp;&nbsp;&nbsp; New Mexico

7.9.6&nbsp;&nbsp;&nbsp; Idaho

7.9.7&nbsp;&nbsp;&nbsp; Montana

7.9.8&nbsp;&nbsp;&nbsp; Wyoming

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Key players

8.1.1&nbsp;&nbsp;&nbsp; angiodynamics

8.1.2&nbsp;&nbsp;&nbsp; Asahi KASEI

8.1.3&nbsp;&nbsp;&nbsp; B. Braun

8.1.4&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

8.1.5&nbsp;&nbsp;&nbsp; DaVita

8.1.6&nbsp;&nbsp;&nbsp; Fresenius

8.1.7&nbsp;&nbsp;&nbsp; Mozarc Medical

8.1.8&nbsp;&nbsp;&nbsp; Teleflex

8.1.9&nbsp;&nbsp;&nbsp; TERUMO

8.1.10&nbsp;&nbsp;&nbsp;U.S. RENAL CARE

8.1.11&nbsp;&nbsp;&nbsp;Vantive (Baxter)

8.2&nbsp;&nbsp;&nbsp; Emerging players

8.2.1&nbsp;&nbsp;&nbsp; JMS

8.2.2&nbsp;&nbsp;&nbsp; NIKKISO

8.2.3&nbsp;&nbsp;&nbsp; NIPRO

8.2.4&nbsp;&nbsp;&nbsp; Northwest Kidney Centers

8.2.5&nbsp;&nbsp;&nbsp; POLYMED

8.2.6&nbsp;&nbsp;&nbsp; Rogosin Institute

8.2.7&nbsp;&nbsp;&nbsp; SATELLITE HEALTHCARE

8.2.8&nbsp;&nbsp;&nbsp; TORAY

8.2.9&nbsp;&nbsp;&nbsp; UTAH MEDICAL PRODUCTS INC.

&nbsp;&nbsp;&nbsp;

US Dialysis Market

Get a free sample of this report